cancer research

Greek Investigator Seeks to Make CAR-T Far Cheaper than Novartis & Kite Pharma!

  NeoCosmos reports a Greek assistant professor of medicine at the VUmc Cancer Centre in Amsterdam, Dr. Maria Themeli, is determined to make her patent...

Tech Transfer & Drug Prices: The Best of Times and the Worst of Times

These are the best and worst of times in all facets of life, including drug development. Breakthrough treatments can extend survival by many years—what...
Drug Pricing

ICER’s Growing Impact on Drug Pricing & Reimbursement

Forbes reports on the growing clout of the Institute for Clinical and Economic Review (ICER).  Sometimes referred to American’s ‘NICE’ a reference to the...

Otezla; An Introduction

An estimated 7.5 million live with psoriasis in the United States alone. An autoimmune disease that surfaces on the skin as raised, red itchy...

UCLA Research Study Cost Effectiveness of Rectal Cancer Treatments

UCLA researchers are seeking cost-effective methods to treat patients with locally advanced rectal cancer according to a recent report from UCLA newsroom.  The researchers...
spinal muscular atrophy

Biogen Faces Challenges to SMA Drug Price

Motley Fool covers an ICER analysis of Biogen’s leading drug—and it doesn’t look good according to Cory Renauer. Biogen (NASDAQ: BIIB) may be in...
China regulatory

Can Cheaper Drugs Help Home-Grown Labs Turn the Table on Foreign Big Pharma in...

China represents a global battle ground for the cancer drug market.  Nearly a quarter of the world’s newly diagnosed cancer cases in 2015 were...

Maryland Legislation Driving to Bring Prescription Drug Affordability Board to State

Driven by the State of Maryland legislature, a new type of drug affordability board represents the first of its kind and industry sponsors should...

Novartis Drug Wins FDA Approval Despite Challenges to its $88K Price

Novartis drug Mayzent was approved for multiple sclerosis.  Novartis has established a price at $88,000 per year. It exceeds most MS drugs and will...

Psoriasis Patient Takes Autoimmune Disorder to Facebook Live and Shares Struggles

As reported in WNEM by Coty Kuschinsky, Randi O’Connor has taken her battle with Psoriasis, what she thought was a skin disorder, to Facebook...